Singapore markets closed

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3562-0.0018 (-0.50%)
At close: 04:00PM EDT
0.3580 +0.00 (+0.51%)
Pre-market: 07:11AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 36.69M
Enterprise value 36.28M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)88.08
Price/book (mrq)7.42
Enterprise value/revenue 96.23
Enterprise value/EBITDA -0.36

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-76.88%
S&P500 52-week change 3-13.21%
52-week high 32.3400
52-week low 30.3500
50-day moving average 30.4662
200-day moving average 30.8797

Share statistics

Avg vol (3-month) 3487.36k
Avg vol (10-day) 3407.87k
Shares outstanding 598.42M
Implied shares outstanding 6N/A
Float 888.93M
% held by insiders 19.66%
% held by institutions 19.90%
Shares short (14 Mar 2023) 47.13M
Short ratio (14 Mar 2023) 416.02
Short % of float (14 Mar 2023) 47.80%
Short % of shares outstanding (14 Mar 2023) 47.25%
Shares short (prior month 14 Feb 2023) 46.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 0.00%
Operating margin (ttm)-24,118.57%

Management effectiveness

Return on assets (ttm)-80.63%
Return on equity (ttm)-228.52%

Income statement

Revenue (ttm)377k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-62.70%
Gross profit (ttm)-3.24M
EBITDA -88.47M
Net income avi to common (ttm)-89.26M
Diluted EPS (ttm)-0.9900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)42.75M
Total cash per share (mrq)0.43
Total debt (mrq)36.64M
Total debt/equity (mrq)335.07
Current ratio (mrq)1.07
Book value per share (mrq)-0.13

Cash flow statement

Operating cash flow (ttm)-70.98M
Levered free cash flow (ttm)-36.11M